Anti-HIV-1 activity of weekly or biweekly treatment with subcutaneous PRO 140, a CCR5 monoclonal antibody.
Jacobson JM; Thompson MA; Lalezari JP; Saag MS; Zingman BS; D'Ambrosio P; Stambler N; Rotshteyn Y; Marozsan AJ; Maddon PJ; Morris SA; Olson WC; The Journal Of Infectious Diseases, 2010, vol. 201, issue 10, p 1481, ISSN 15376613. ISBN 15376613.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef